Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

When it came to cardiovascular incidents, the report showed major gains for GLP-1 users, too. 44% experienced fewer ...

Compounded Ozempic and Wegovy, cheaper generic versions of the weight-loss drugs, can no longer be sold. Doctor explains ...

TikTok creator Janelle Rohner revealed she is taking a GLP-1 medication for weight loss — despite selling $200 courses to ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity epidemic, according to Reuters.

A decision is expected in the fourth quarter of 2025.

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

While these medications offer unprecedented health benefits, they come with challenges like cost, non-adherence and lack of ...

The company’s health services division Evernorth is doubling down on a reliable growth area: assuaging payer concerns around ...

Full Frame Growth Partners is a minority investor in California-based Supergut, a company making powdered supplements and ...